New York City-headquartered investment firm KKR, signed definitive agreements to become the largest shareholder and take control of Healthcare Global Enterprises (HCG) based in Bangalore, India.
The transaction involves KKR acquiring up to 54% equity stake in HCG from Luxembourg-based CVC Capital Partners at a deal valued at $400 million
HCG, founded in 1989, is one of India’s largest oncology hospital chains, operating 25 medical centers across 19 cities. The organization’s infrastructure includes 2,500 beds, approximately 100 operating theaters, and 40 linear accelerator machines.
Akshay Tanna, partner and head of India Private Equity at KKR, emphasized that healthcare remains a key thematic focus for KKR in India. He expressed commitment to leveraging KKR’s global healthcare expertise to strengthen HCG’s offerings. The investment aims to support the development of medical infrastructure and expand access to critical oncology services across India.
The investment comes from KKR’s Asia Fund IV and represents their latest venture in India’s healthcare sector. The transaction is anticipated to close by the third quarter of 2025, subject to standard closing conditions and regulatory approvals.
This deal adds to KKR’s healthcare investments in India such as Infinx, Max Healthcare, JB, Gland Pharma, as well as medical devices maker Healthium.
Last updated: December 26th, 2025
